Avai Bio (AVAI) Non-Current Assets (2018 - 2023)
Avai Bio's Non-Current Assets history spans 5 years, with the latest figure at $253199.0 for Q4 2023.
- For Q4 2023, Non-Current Assets rose 83.86% year-over-year to $253199.0; the TTM value through Dec 2023 reached $924335.0, up 113.5%, while the annual FY2023 figure was $133885.0, N/A changed from the prior year.
- Non-Current Assets for Q4 2023 was $253199.0 at Avai Bio, down from $263467.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $273784.0 in Q2 2023 and bottomed at $320.0 in Q4 2019.
- The 4-year median for Non-Current Assets is $51033.0 (2020), against an average of $99951.3.
- The largest annual shift saw Non-Current Assets tumbled 96.16% in 2019 before it skyrocketed 8105.94% in 2020.
- A 4-year view of Non-Current Assets shows it stood at $320.0 in 2019, then surged by 8105.94% to $26259.0 in 2020, then skyrocketed by 424.43% to $137710.0 in 2022, then soared by 83.86% to $253199.0 in 2023.
- Per Business Quant, the three most recent readings for AVAI's Non-Current Assets are $253199.0 (Q4 2023), $263467.0 (Q3 2023), and $273784.0 (Q2 2023).